[Costs and problems in cervix cancer screening are considerably underestimated].
Bistoletti
P
P
Karolinska institutet, kvinnokliniken, Huddinge Universitetssjukhus. peter.bistoletti@obgyn.hs.sll.se
D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D013548:Sweden; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000473:pathology / Q000517:prevention & control*; D014626:Vaginal Smears / Q000009:adverse effects / Q000191:economics*